Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study.

Saved in:
Bibliographic Details
Title: Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study.
Authors: Greenberg BR; Division of Hematology-Oncology, University of Connecticut Health Center, Farmington 06030., Reynolds RD, Charron CB, Squillace KM, Lessin LS, Case DC Jr, Gams RA
Source: Cancer [Cancer] 1993 Mar 15; Vol. 71 (6), pp. 1989-92.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0008-543X
DOI:10.1002/1097-0142(19930315)71:6<1989::aid-cncr2820710611>3.0.co;2-t